BR112015026384A2 - methods for protein and peptide expression - Google Patents

methods for protein and peptide expression

Info

Publication number
BR112015026384A2
BR112015026384A2 BR112015026384A BR112015026384A BR112015026384A2 BR 112015026384 A2 BR112015026384 A2 BR 112015026384A2 BR 112015026384 A BR112015026384 A BR 112015026384A BR 112015026384 A BR112015026384 A BR 112015026384A BR 112015026384 A2 BR112015026384 A2 BR 112015026384A2
Authority
BR
Brazil
Prior art keywords
methods
protein
peptide expression
allocrits
proi
Prior art date
Application number
BR112015026384A
Other languages
Portuguese (pt)
Other versions
BR112015026384B1 (en
BR112015026384A8 (en
Inventor
Schwarz Christian
Schmitt Lutz
Hendrikus Joannes Smits Sander
Original Assignee
Heinrich Heine Univ Duesseldorf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Heine Univ Duesseldorf filed Critical Heinrich Heine Univ Duesseldorf
Publication of BR112015026384A2 publication Critical patent/BR112015026384A2/en
Publication of BR112015026384A8 publication Critical patent/BR112015026384A8/en
Publication of BR112015026384B1 publication Critical patent/BR112015026384B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y208/00—Transferases transferring sulfur-containing groups (2.8)
    • C12Y208/01—Sulfurtransferases (2.8.1)
    • C12Y208/01008—Lipoyl synthase (2.8.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y406/00—Phosphorus-oxygen lyases (4.6)
    • C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
    • C12Y406/01001—Aodenylate cyclase (4.6.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

resumo “métodos para a expressão de proteínas e peptídeos” a presente invenção se refere ao campo da biologia molecular, expressão de proteína e peptídeo recombinante e se relaciona a métodos compreendendo sequências de ácido nucleicos compreendendo alócritos de t1sss ou fragmentos dos mesmos para a produção eficiente de peois ou proi recombinante. os alócritos ou fragmentos dos mesmos melhoram a expressão do peoi ou proi como ib e função como marcadores-ib.abstract "methods for expressing proteins and peptides" the present invention relates to the field of molecular biology, recombinant protein and peptide expression and relates to methods comprising nucleic acid sequences comprising t1sss allocrits or fragments thereof for efficient production of recombinant peols or proI. allocrits or fragments thereof enhance expression of peoi or proi as ib and function as ib-markers.

BR112015026384-4A 2013-04-17 2014-04-17 METHOD FOR PRODUCING RECOMBINANT PEPTIDE (PEOI) OR PROTEIN OF INTEREST (PROI) BR112015026384B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13164098.9A EP2792686A1 (en) 2013-04-17 2013-04-17 Methods for the expression of peptides and proteins
EP13164098.9 2013-04-17
PCT/EP2014/057887 WO2014170430A1 (en) 2013-04-17 2014-04-17 Methods for the expression of peptides and proteins

Publications (3)

Publication Number Publication Date
BR112015026384A2 true BR112015026384A2 (en) 2017-10-10
BR112015026384A8 BR112015026384A8 (en) 2018-05-22
BR112015026384B1 BR112015026384B1 (en) 2023-07-18

Family

ID=

Also Published As

Publication number Publication date
AU2014255697B2 (en) 2017-08-10
PT2986633T (en) 2018-03-08
US10443081B2 (en) 2019-10-15
ES2661404T3 (en) 2018-03-28
NO2986633T3 (en) 2018-06-30
US20160138066A1 (en) 2016-05-19
JP2016515396A (en) 2016-05-30
CN105473609A (en) 2016-04-06
EP2986633A1 (en) 2016-02-24
CA2912300C (en) 2023-01-24
EP2986633B1 (en) 2018-01-31
PL2986633T3 (en) 2018-06-29
WO2014170430A1 (en) 2014-10-23
AU2014255697A1 (en) 2015-12-03
EP2792686A1 (en) 2014-10-22
JP6714902B2 (en) 2020-07-01
TR201802551T4 (en) 2018-03-21
CA2912300A1 (en) 2014-10-23
BR112015026384A8 (en) 2018-05-22
DK2986633T3 (en) 2018-03-12

Similar Documents

Publication Publication Date Title
CY1122800T1 (en) COMPOSITIONS OF FACTOR VIII AND METHODS OF MAKING AND USING THEM
CY1124106T1 (en) CARRIER-ANTIBODY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
BR112018073761A2 (en) single chain variable fragment cd3 binding proteins
CY1125392T1 (en) COMPOSITIONS AND METHODS OF PROTEINS
TWI799368B (en) Anti-tl1a antigen binding proteins and related nucleic acids, expression vectors, host cells, pharmaceutical composition, methods and uses
EA201792573A1 (en) TRISPECIFIC RELATED PROTEINS AND METHODS OF THEIR APPLICATION
DK2831241T3 (en) ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN OR PEPTIDE EXPRESSION.
BR112019003798A2 (en) food products comprising milk proteins and non-animal proteins, and production methods thereof
EA201491644A1 (en) PHARMACEUTICAL COMPOSITIONS
BR112015023431A2 (en) bispecific fc molecules
WO2015037000A8 (en) Vstm5 polypeptides and uses thereof for treatment of cancer, infectious diseases and immune related diseases
BR112016023769A2 (en) recombinant host cell for expression of proteins of interest
BR112016023304A2 (en) recombinant host cell engineered to overexpress helper proteins
CO6690759A2 (en) Antibodies, binding fragments or derivatives thereof that specifically bind to 4-1 bb protein
BR112015019879A2 (en) SPECIES COMPOSITIONS OF MODULATED LYSINE VARIANTS AND METHODS FOR THE PRODUCTION AND USE OF THEM
BR112015004467A2 (en) method for controlling protein heterogeneity
CA2872308A1 (en) Novel ha binding agents
MA41313A (en) MODIFIED APRIL PROTEIN BINDING ANTIBODIES
EA201491784A1 (en) Antibodies Against Ligand Recorder B1 Bradykinin
CR20170197A (en) PROTEINS OF VARIANTS OF SEQUENCES OF AMINO ACIDS OF CRY1DA1 ACTIVE FOR LEPIDOPTERS
UY34663A (en) NUCLEIC ACID AND RECOMBINANT PROTEIN OF THE AXMI345 ENDOTOXINE GENE, VECTORS, CELLS, COMPOSITIONS AND METHODS TO PROTECT PLANTS
BR112016020822A2 (en) METHODS AND COMPOSITIONS FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES
BR112016024462A2 (en) Methods for the preparation of a protein, heteromultimeric protein, composition and host cell.
MD20150109A2 (en) Mitochondrial proteins constructs and uses thereof
AR092879A1 (en) G3P FUSION PROTEINS AS AGENTS OF UNION TO AMILOIDE

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: NUMAFERM GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/04/2014, OBSERVADAS AS CONDICOES LEGAIS